Nanjing Well Pharmaceutical Group (603351.SH): has research related to liposomes.

Gelonghui, December 26th丨Nanjing Well Pharmaceutical Group (603351.SH) stated on the investor interaction platform that the company has research related to liposomes.

Gelonghui FinanceDec 26 18:02

Well Pharmaceuticals: Weill Pharmaceuticals Third Quarter 2024 Report

SZSIOct 24 00:00 · Announcements

Well Pharmaceuticals 2024 Third Quarter Report

SZSIOct 24 00:00 · Announcements

Weil Pharmaceutical\'s announcement on the company\'s main operating data for the third quarter of 2024

SZSIOct 24 00:00 · Announcements

Nanjing Well Pharmaceutical Group (603351.SH) executive Zou Jianguo reduced his shareholding by 9300 shares.

Nanjing Well Pharmaceutical Group (603351.SH) announced that as of September 11, 2024, the time for this shareholding plan...

Zhitong FinanceSep 12 17:17

Nanjing Well Pharmaceutical Group 2024 Semi-Annual Report Summary

SZSIAug 20 00:00 · Announcements